Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

930 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy.
Rieken M, Kluth LA, Xylinas E, Seitz C, Fajkovic H, Karakiewicz PI, Lotan Y, Briganti A, Loidl W, Faison T, Crivelli JJ, Scherr DS, Bachmann A, Tewari AK, Kautzky-Willer A, Pummer K, Shariat SF. Rieken M, et al. Among authors: tewari ak. Prostate Cancer Prostatic Dis. 2013 Dec;16(4):367-71. doi: 10.1038/pcan.2013.31. Epub 2013 Sep 3. Prostate Cancer Prostatic Dis. 2013. PMID: 23999669
Development and validation of a novel automated Gleason grade and molecular profile that define a highly predictive prostate cancer progression algorithm-based test.
Donovan MJ, Fernandez G, Scott R, Khan FM, Zeineh J, Koll G, Gladoun N, Charytonowicz E, Tewari A, Cordon-Cardo C. Donovan MJ, et al. Among authors: tewari a. Prostate Cancer Prostatic Dis. 2018 Nov;21(4):594-603. doi: 10.1038/s41391-018-0067-4. Epub 2018 Aug 7. Prostate Cancer Prostatic Dis. 2018. PMID: 30087426
MRI-Targeted Biopsy for Prostate-Cancer Diagnosis.
Martini A, Cumarasamy S, Tewari AK. Martini A, et al. Among authors: tewari ak. N Engl J Med. 2018 Aug 9;379(6):589. doi: 10.1056/NEJMc1807507. N Engl J Med. 2018. PMID: 30091345 No abstract available.
Defining Prostate Cancer at Favorable Intermediate Risk: The Potential Utility of Magnetic Resonance Imaging and Genomic Tests.
Falagario UG, Beksac AT, Martini A, Cumarasamy S, Gupta A, Prasad S, Thulasidass H, Shah QN, Jayaratna I, Lewis S, Rastinehad AR, Taouli B, Cormio L, Carrieri G, Tewari AK. Falagario UG, et al. Among authors: tewari ak. J Urol. 2019 Jul;202(1):102-107. doi: 10.1097/JU.0000000000000134. Epub 2019 Jun 7. J Urol. 2019. PMID: 30730408
Avoiding Unnecessary Magnetic Resonance Imaging (MRI) and Biopsies: Negative and Positive Predictive Value of MRI According to Prostate-specific Antigen Density, 4Kscore and Risk Calculators.
Falagario UG, Martini A, Wajswol E, Treacy PJ, Ratnani P, Jambor I, Anastos H, Lewis S, Haines K, Cormio L, Carrieri G, Rastinehad AR, Wiklund P, Tewari A. Falagario UG, et al. Among authors: tewari a. Eur Urol Oncol. 2020 Oct;3(5):700-704. doi: 10.1016/j.euo.2019.08.015. Epub 2019 Sep 20. Eur Urol Oncol. 2020. PMID: 31548130
930 results